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REVIEW
NONINVASIVE MECHANICAL VENTILATION IN THE
TREATMENT OF ACUTE CARDIOGENIC PULMONARY
EDEMA
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Current literature was searched by using the MEDLINE database to find consistent evidence regarding the use of noninvasive
mechanical ventilation in patients with acute cardiogenic pulmonary edema. 18 studies demonstrating that noninvasive ventilation
applied by continuous positive airway pressure (CPAP) or bilevel positive airway pressure (bilevel-PAP) is safe, and that the two
approaches have similar effects and are effective in preventing endotracheal intubation in patients with respiratory distress of
cardiac origin, were found. The results support the concept that positive intrathoracic positive pressure must be seen as a
nonpharmacological form of treatment of acute pulmonary edema rather than only a supportive measure.
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INTRODUCTION
Acute cardiogenic pulmonary edema is a common cause
of acute respiratory distress among patients presenting to
the emergency departments and intensive care units.
Hypoxemia, sometimes associated with hypercapnia, is a
common feature in the clinical presentation of acute
cardiogenic pulmonary edema. Standard medical therapy
includes diuretics, vasodilators, and inotropics, and it re-
sults in rapid improvement of the respiratory symptoms.
In this context, oxygen delivered through a face mask is
the basic respiratory support. Although many patients re-
spond rapidly to standard treatment, a significant number
progress to severe respiratory distress leading to endotra-
cheal intubation with its associated complications.1–9
Positive pressure applied in the airway can relieve the
respiratory failure and also improve the cardiovascular
function, especially in severe cardiac-dysfunction pa-
tients.10,11 These multiple actions of positive pressure can
act synergically in the treatment of patients with respira-
tory distress and impaired cardiac function.1–9,12 Noninvasive
use of positive pressure delivered through a face mask re-
duces the need for endotracheal intubation in patients with
acute cardiogenic pulmonary edema.1–9
There are 2 modes for applying noninvasive positive
pressure: continuous positive airway pressure (CPAP) (ie,
constant pressure during the whole respiratory cycle) and
bilevel positive airway pressure (bilevel-PAP) (ie, adding
to a continuous expiratory pressure an inspiratory support
pressure above the expiratory pressure to reduce the inspi-
rational respiratory work). In this report, we review the
main physiological characteristics of CPAP and bilevel-PAP
on respiratory and cardiovascular function as well as the
evidences to their use in the clinical setting.
CARDIOVASCULAR AND RESPIRATORY
PHYSIOLOGY
Cardiovascular effects of positive pressure ventilation
are primarily modulated by the effects on preload and
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afterload. Venous return can be reduced when positive pres-
sure ventilation is applied in hypovolemic patients, result-
ing in reduced cardiac output. In normovolemic patients,
the pulmonary insufflation raises the abdominal pressure,
and thus it raises the mean circulatory pressure, keeping
the venous flow stable.13 Pleural pressure augmentation
raises the pericardial pressure and reduces the myocardial
transmural pressure as well as the ventricle diameter,14 re-
sulting in low ventricle surface tension and afterload,
mainly in patients with a dilated ventricle.10,11,15 This
anatomo-physiological alteration is associated with a re-
duction in regurgitant flow through the mitral valve.11
Airway positive pressure has well-known effects on res-
piratory function in patients with cardiogenic pulmonary
edema. The improvement in pulmonary compliance and
shunt are associated with alveolar recruitment.10,15 Reduc-
tion of inspiratory load is associated with the improvement
of pulmonary compliance and the inspiratory pressure sup-
port when bilevel-PAP is applied.10,15 A CPAP of 10 cm H2O
reduces the pleural pressure swing and improves tidal vol-
ume and PaO2/FiO2 ratio during the spontaneous ventila-
tion in patients with heart failure; these effects are more
striking when using bilevel-PAP ventilation with an expira-
tory pressure (EPAP) of 10 cm H2O and inspiratory pres-
sure (IPAP) of 15 cm H2O.10,15
CLINICAL USE OF NONINVASIVE POSITIVE
PRESSURE VENTILATION IN ACUTE
CARDIOGENIC PULMONARY EDEMA
Continuous possitive airway pressure (CPAP)
Two randomized studies have shown an improvement
in hypoxemia, hypercapnia, and endotracheal intubation
rate in patients with acute cardiogenic pulmonary edema
using CPAP as compared to treatment with standard respi-
ratory support (ie, oxygen delivered by mask).1,2,9 These re-
sults have been reproduced in small physiological trials5–
7,9,16
 as well as in other clinical trials.5,6,9 The impact of
CPAP on mortality in patients with acute cardiogenic pul-
monary, was reduced in some trials5,7,9 but not in others.1,2
The different results obtained may be related to meth-
odology, including patient selection and levels of CPAP.
One interesting point is that in the first randomized trial,1
the patients enrolled were severely hypercapnic. In addi-
tion, the improvement in PaCO2 after 30 minutes was sig-
nificantly greater in the CPAP group (58 ± 8 to 46 ± 4 mm
Hg) than in the oxygen group (64 ± 17 to 62 ± 14 mm Hg).
The levels of CPAP used in the trials varied, but most
of them used 10 cm H2O.1,5,7 Alternatively, in one trial, the
level of CPAP was titrated from 2.5 cm H2O to 12.5 cm
H2O over 2.5 hours.2 Park et al6 showed that 5 cm H2O of
CPAP was not superior to conventional therapy in terms
of tracheal intubation. Taken together, the target CPAP pres-
sure for patients with acute pulmonary edema should be
10 cm H2O for most patients.
Bilevel positive airway pressure (bilevel-PAP)
The effectiveness of the use of bilevel-PAP in the treat-
ment of acute cardiogenic pulmonary edema has been
tested in 6 clinical trials, with different results.3–8 These dif-
ferences may be related to different methodologies. Com-
paring bilevel-PAP with oxygen, Masip et al,4 Nava et al,8
Park et al,5,6 and Crane et al7 have shown physiological im-
provement and reduction in endotracheal intubation rates.
On the other hand, comparing bilevel-PAP and CPAP, Park
et al5 and Crane et al7 did not find physiological or clini-
cal improvement. Mehta et al3 found physiological im-
provement but with a rise in myocardial infarction rate. In
a pilot study comparing bilevel-PAP and CPAP, Park et al6
found that 5 cm H2O of CPAP was not associated with
avoidance of endotracheal intubations, but bilevel-PAP with
an expiratory pressure (EPAP) of 3 cm H2O and inspira-
tory pressure (IPAP) of 8 cm H2O was.
The various levels of airway pressure used in those tri-
als might explain some result differences among them.
Nava et al,8 in a multicenter European trial, enrolled 130
patients, 65 to oxygen support treatment and 65 to bilevel-
PAP with a mean EPAP of 6.1 ± 3.2 cm H2O and a mean
IPAP of 14.5 ± 21.1 cm H2O over 11.4 ± 3.6 hours. In this
trial, normocapnic (PaCO2 d•45 mm Hg) patients using
bilevel-PAP showed no improvement in endotracheal intu-
bation and mortality rates, whereas, hypercapnic (PaCO2
> 45 mm Hg) patients had a reduction in endotracheal in-
tubation rates (oxygen, 29% vs bilevel-PAP, 6%. P =
0.015). This finding was similar to that of Masip et al,4
where hypercapnic patients had a substantial physiologi-
cal and probably clinical improvement when compared to
normocapnic patients using similar airway pressures to
those used by Nava et al.8 The incidence of hypercapnic
patients was 49% in the study by Nava et al8 study, and it
was 50% in the study by Masip et al.4 In contrast, Park et
al 5 found that even normo- or hypocapnic patients can ex-
perience beneficial effects in physiological and clinical
terms from bilevel-PAP ventilation in an acute cardiogenic
pulmonary edema setting, when compared to oxygen-alone
treated patients. In the last study, 80 patients were enrolled,
26 to receive oxygen only, 27 to receive CPAP (10 cm
H2O), and 27 to receive bilevel-PAP (EPAP = 10 cm H2O
and IPAP = 15 cm H2O); 19% of these patients were hy-
percapnic. The endotracheal intubation rate was 42% in the
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oxygen-alone group and 7% in bilevel-PAP group. There
are some differences in the populations enrolled to the stud-
ies of Nava et al8 and Park et al,5 but the most striking dif-
ference was the EPAP level used (5 cm H2O vs 10 cm H2O).
The real importance of the effect of EPAP on the respira-
tory and cardiovascular function is not yet clear in this set-
ting, but it should be considered that 10 cm H2O of EPAP
can be safe and maybe more useful for supporting and treat-
ing acute cardiogenic pulmonary edema patients.5 An in-
spiratory support pressure of 5 cm H2O seems to be suffi-
cient to relieve the respiratory distress and improve
hemodynamic and respiratory variables.5,10,15
In a study comparing bilevel-PAP and high-dose nitrate
therapy, Sharon et al17 found an increased myocardial inf-
arction rate in the bilevel-PAP group. However, this study
did not have an adequate control group, the rate of myo-
cardial infarction was much higher than the other cited
studies,4–8,16,18,19 and the diagnostic criteria of myocardial
infarction was poor.
There is no conclusion about the mortality rate in acute
cardiogenic pulmonary edema patients treated with bilevel-
PAP when compared to conventional treatment. In fact,
only 1 study, performed by Park et al,5 has shown a reduc-
tion of mortality associated with bilevel-PAP at the 15-day
follow-up. Other studies, such as those of Masip et al,4 Nava
et al,8 and Crane et al7 did not find a reduction in mortal-
ity rates, although there were different strategies in the res-
piratory support of patients.
CPAP VS BILEVEL-PAP
The use of CPAP or bilevel-PAP as a choice to treat
and support acute pulmonary edema patients has recently
been explored and reported. Mehta et al3 studied 27 pa-
tients, with 13 enrolled to receive CPAP at 10 cm H2O, and
14 enrolled to receive nasal bilevel-PAP with an EPAP of
5 cm H2O and an IPAP of 15 cm H2O; they found an im-
provement in 30 minutes in the bilevel-PAP–treated group
that was more accentuated in physiological outcomes such
as heart rate, respiratory rate, PaO2, and PaCO2. In clinical
terms, there was an improvement in the dyspnea score, but
the study had to be prematurely stopped due to a high in-
cidence of myocardial infarctions in the bilevel-PAP group.
The causes of this unexpected event were not clarified. The
authors suggested that the excessive intrathoracic pressure
associated with bilevel-PAP was responsible for the adverse
cardiovascular effects. However, when taking into account
that the patients had presented with chest pain in the emer-
gency room, it seems that in the 71% patients who were
randomized to be treated with bilevel-PAP and presented
CK-MB elevations, the myocardial infarction may have
actually been the cause of the pulmonary edema and not
the result of bilevel-PAP ventilation. More recently Park
et al,5,6 Cross et al,18 and Crane et al7 have found that CPAP
was similar to bilevel-PAP in physiological and clinical
outcomes, including a similar incidence of acute myocar-
dial infarction rate. However, in the last study, CPAP was
associated with an improvement in in-hospital survival.7
Facing hypercapnic acute cardiogenic pulmonary edema
patients, the rationale to use bilevel-PAP is strong.3,1015
However, in contrast to the studies of Masip et al4 and Nava
et al,8 where the hypercapnic patients seemed to be better
supported by bilevel-PAP, the study performed by Bersten
et al,1 a CPAP of 10 cm H2O was also effective in reduc-
ing the need for endotracheal intubation. Accordingly,
Bellone et al,19 in a randomized, prospective study, found
with high statistical power (0.8) that 18 hypercapnic acute
cardiogenic pulmonary edema patients ventilated with a
CPAP of 10 cm H2O had a similar endotracheal intubation
requirement to that of 36 patients ventilated with bilevel-
PAP with an EPAP = 5 cm H2O and pressure support suf-
ficient to achieve 400 mL of tidal volume (CPAP = 5.5%
vs bilevel-PAP = 11.1%, P = 0.5). The odds ratio graph of
endotracheal intubation requirements of all studies com-
paring CPAP and bilevel-PAP are shown in Figure 1.
The issue of acute myocardial infarction was better stud-
ied in the trial of Bellone et al,16 where with a statistical
power of 0.8, the incidence of acute myocardial infarct was
similar in both groups studied: 13.6% of 22 patients treated
with CPAP of 10 cm H2O and 8.4% of 24 patients treated
with bilevel-PAP with an EPAP of 5 cm H2O and IPAP of
15 cm H2O (P = 0.46). The odds ratio graph of acute myo-
cardial infarction after admission of all studies comparing
CPAP and bilevel-PAP is shown in Figure 2.
SEVERITY AND TIMING FOR APPLICATION OF
NONINVASIVE VENTILATION
Pulmonary edema has a wide spectrum of severity, and
few patients have severe respiratory distress at entry into a
study. In the study of Parket al,5 as in others,4 only 20% of
the patients evaluated were enrolled with severe pulmonary
edema. Therefore, it is likely that the effects of noninvasive
ventilation are not uniform across the whole spectrum of
cardiogenic pulmonary edema.20 In studies such as those
of Nava et al,8 Park et al,5,6 Masip et al,4 and Crane et al,7
the presence of a control group treated with oxygen allowed
us to estimate the expected outcome for the particular popu-
lation selected.
A delay in applying noninvasive ventilation is a possi-
ble explanation for hypercapnia in some patients.4 In con-
trast, when applying positive airway pressure early, low lev-
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Figure 2 - ODDS ratio of acute myocardial infarction in the studies comparing CPAP and bilevel-PAP
Figure 1 - ODDS ratio of endotracheal intubation requirement in the studies comparing CPAP and bilevel-PAP
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els of pressure may not be useful,8 but higher expiratory
pressure levels can reduce the requirement for endotracheal
intubation.5
CONCLUSION
In conclusion, the analysis of the current literature
shows that noninvasive ventilation applied by CPAP or
bilevel-PAP is safe, and the two approaches have similar
effects and are effective in preventing the need for endotra-
cheal intubation in patients with respiratory distress of car-
diac origin. The results support the concept that positive
intrathoracic positive pressure must be seen as a
nonpharmacological form of treatment of acute pulmonary
edema, rather than only as a supportive measure.
Park M, Lorenzi-Filho G. Uso da ventilação não invasiva
no tratamento de pacientes com edema agudo de pulmão
cardiogênico. Clinics. 2006;61(3):247-52.
Pesquisamos a literatura atual usando a base de dados
MEDLINE para encontrar evidências consistentes sobre o
uso da ventilação não invasiva em pacientes com edema
agudo de pulmão cardiogênico. Foram encontrados 18
estudos demonstrando que a ventilação não invasiva aplicada
por CPAP ou bilevel-PAP é segura, tem efeitos similares e
RESUMO
é efetiva em reduzir a necessidade de intubação traqueal em
pacientes com desconforto respiratório de origem cardíaca.
Os resultados reforçam o conceito que a pressão positiva
intratorácica deve ser considerada um forma não farmaco-
lógica de tratamento do edema agudo de pulmão cardio-
gênico e não simplesmente uma medida de suporte.
UNITERMOS: Edema pulmonar. Insuficiência respira-
tória. Respiração artificial. Ventilação mecânica. Terapia
respiratória.
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